Menu
ETF
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-74.34 M USD-143.45 M USD-43.29 M USD-89.37 M USD-44.06 M USD-15.42 M USD-35.21 M USD-25.20 M USD-24.10 M USD-39.10 M USD-34.70 M USD-22.62 M USD
Depreciation & Amortization9.26 M USD12.52 M USD12.67 M USD6.22 M USD3.22 M USD4.01 M USD4.61 M USD5.37 M USD7.41 M USD6.74 M USD4.92 M USD4.06 M USD
Stock-Based Compensation29.61 M USD31.73 M USD13.12 M USD14.88 M USD16.10 M USD14.45 M USD11.39 M USD11.02 M USD9.09 M USD13.86 M USD16.83 M USD20.94 M USD
Capital Expenditures8.30 M USD8.36 M USD2.83 M USD3.83 M USD13.26 M USD12.72 M USD2.53 M USD372000 USD1.57 M USD5.07 M USD3.98 M USD7.40 M USD
Cash Flow from Investing27.41 M USD363.17 M USD20.24 M USD-88.13 M USD-11.95 M USD39.98 M USD-39.30 M USD4.72 M USD17.66 M USD45.10 M USD25.74 M USD-178.38 M USD
Cash Flow from Financing570000 USD-102.62 M USD-6.81 M USD230.76 M USD15.96 M USD20.86 M USD2.79 M USD57.66 M USD29.00 M USD76000 USD5.30 M USD200.33 M USD
Dividends Paid
Stock Buybacks0 USD40.49 M USD5.41 M USD563000 USD0 USD
Free Cash Flow-82.65 M USD-151.81 M USD-46.12 M USD-93.19 M USD-57.33 M USD-28.13 M USD-37.74 M USD-25.57 M USD-25.66 M USD-44.16 M USD-38.68 M USD-30.03 M USD

Standard Biotools Inc. is a leading developer and provider of innovative life sciences tools and solutions. This company focuses on empowering researchers by delivering precision instruments and systems essential for high-throughput DNA sequencing, protein analysis, and molecular diagnostics. With a commitment to advancing healthcare and scientific discovery, Standard Biotools provides critical support to industries such as biotechnology, pharmaceuticals, and academic research institutions. Their cutting-edge platforms facilitate more effective and efficient data analysis, enabling breakthroughs in personalized medicine and disease understanding. Headquartered in the United States, Standard Biotools Inc. plays a vital role in the life sciences sector, frequently collaborating with research entities to propel forward the capabilities of modern biological technology. This company's contributions are crucial in addressing global health challenges and paving the way for future innovations in the scientific community.